Petros Pharmaceuticals Net Profit Margin Growth & History (PTPI)
Petros Pharmaceuticals's net profit margin was −280.10% for fiscal 2024.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −280.10% | −139.90 pp |
| 2023 | 2023-12-31 | −140.20% | +194.20 pp |
| 2022 | 2022-12-31 | −334.40% | −219.35 pp |
| 2021 | 2021-12-31 | −115.05% | +100.30 pp |
| 2020 | 2020-12-31 | −215.35% | — |
Petros Pharmaceuticals quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −1,278.39% | — |
| Q3 2024 | 2024-09-30 | −140.87% | +130.80 pp |
| Q2 2024 | 2024-06-30 | −46.57% | +81.14 pp |
| Q1 2024 | 2024-03-31 | −155.72% | −100.71 pp |
| Q3 2023 | 2023-09-30 | −271.67% | — |
| Q2 2023 | 2023-06-30 | −127.72% | −84.44 pp |
| Q1 2023 | 2023-03-31 | −55.01% | −47.94 pp |
| Q4 2022 | 2022-12-31 | −528.93% | — |
| Q2 2022 | 2022-06-30 | −43.28% | +42.70 pp |
| Q1 2022 | 2022-03-31 | −7.07% | −80.90 pp |
| Q3 2021 | 2021-09-30 | −79.10% | +16.15 pp |
| Q2 2021 | 2021-06-30 | −85.97% | +333.69 pp |
| Q1 2021 | 2021-03-31 | 73.83% | +413.31 pp |
| Q4 2020 | 2020-12-31 | −185.64% | — |
| Q3 2020 | 2020-09-30 | −95.26% | — |
| Q2 2020 | 2020-06-30 | −419.67% | — |
| Q1 2020 | 2020-03-31 | −339.48% | — |
Petros Pharmaceuticals net profit margin trends
Between the periods ended 2020-12-31 and 2024-12-31, Petros Pharmaceuticals's net profit margin decreased from −215.35% to −280.10%, a change of −64.75 percentage points. The latest reported quarter, Q4 2024, shows −1,278.39%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Petros Pharmaceuticals source filings ↗